Fundraising FoxShermatrix
1 known investors
Find your way into Shermatrix
Sign up to see every warm intro you have to Shermatrix
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Shermatrix team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
SherMATRIX develops extracellular matrix (ECM) formulations and bio-adhesives for regenerative medicine, with its most advanced product being an animal-derived ECM bio-adhesive for lung surgery currently in in vitro and in vivo validation. It also offers ECM formulations derived from various tissues and organs for complex cell culture applications, serving surgeons and the medical community.
Founders & leadership
PV
Patrick VermetteProfessor, Faculty of Engineering, Université de Sherbrooke
Investors · 1
Frequently asked questions
- What does Shermatrix do?
- SherMATRIX develops extracellular matrix (ECM) formulations and bio-adhesives for regenerative medicine, with its most advanced product being an animal-derived ECM bio-adhesive for lung surgery currently in in vitro and in vivo validation. It also offers ECM formulations derived from various tissues and organs for complex cell culture applications, serving surgeons and the medical community.
- Who are Shermatrix's investors?
- Shermatrix's investors include ACET Capital.